EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

INF-γ/TGF-β1-primed umbilical cord mesenchymal stem cells boost the T-lymphocytes activity: Modulation of CD25 expression and IL-6 secretion

Abdulrahman H Almaeen iD, Heba M Saad-Eldien iD, Hala Gabr

International Journal of Immunopathology and Pharmacology · 2025

DOI: 10.1177/03946320251315007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Immunopathology and Pharmacology, 2025. Verfasst von Abdulrahman H Almaeen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Medicine, Jouf University, Sakaka, Saudi Arabia. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Interleukin-6, Transforming Growth Factor beta1, T-Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Deanship of Scientific Research at Jouf University for funding this work through the research grant #CV-44-41..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mesenchymal stromal/stem cells (MSCs) have potent immunomodulatory abilities, particularly in a milieu of hyperactive immune system, through secreting a number of cytokines, growth factors, bioactive compounds and peptides, and by cell-cell contact. During viral infection, failure of immuno-neutralization of the viral particles, recruits T-lymphocytes (T-cells) that clear the virally-infected cells. MSCs greatly potentiate T-cells anti-viral activity.

Objective

The objective of this study is to assess the ability of the cytokine-primed MSCs to activated T-cells, towards an antiviral application.

Method

Human umbilical cord MSCs (UC-MSCs) were isolated from Wharton Jelly of a consented donor. UC-MSCs were primed with interferon (INF)-γ and transforming growth factor (TGF)-β1. Peripheral blood T-cells were isolated using mini-max and CD3+ population was purified using anti-CD3 immuno-magnetic beads. Naïve or primed MSCs were co-cultured with naïve and phytohemagglutinin (PHA)-activated CD3+ T-cells. T-cell activation was evaluated by changes in their rate of proliferation by cell count, flowcytometric immuno-phenotyping for CD25 expression, and IL-6 secretion in the conditioned medium.

Results

The findings revealed that CD3+ T-cells count nonsignificant differed comparing the five experimental groups; Naïve MSCs, Naïve T cells, coculture with naïve MSCs, coculture with primed MSCs, and upon phytohemagglutinin-activation, despite a nonsignificant reduction of proliferation in the last two groups’ coculture. Only the coculture with the primed MSCs showed significant activation of T-cells assessed as CD25 expression compared to the other groups ( p < 0.001 and p = 0.002, respectively). The undetectable levels of IL-6 in the conditioned medium of naïve MSCs, turned markedly high after their cytokine-priming ( p < 0.001), reaching nonsignificant difference compared to naïve T-cells. Compared to naïve MSCs, naïve T-cells secreted considerable amounts of IL-6 ( p < 0.001). Incubation of naïve MSCs with phytohemagglutinin-activated T-cells further the secretion of IL-6, to a level significantly higher than all of the aforementioned three groups; naïve MSCs, naïve T-cells and primed MSCs ( p < 0.001, p = 0.0194, and p < 0.001, respectively). However, coculture of the cytokine-primed MSCs with phytohemagglutinin-activated T-cells dampened IL-6 secretion to a level that was significantly lower than that observed with naïve MSCs-phytohemagglutinin-activated T-cells coculture ( p < 0.001).

Conclusion

The cytokine-primed UC-MSCs significantly upregulated CD25+ expression on T-cells, while hindering IL-6, without affecting their proliferation rate. This may point to potentially stronger antiviral effects, while alleviating the viral infection-induced cytokine storm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsInterleukin-6Transforming Growth Factor beta1T-LymphocytesUmbilical CordInterferon-gammaInterleukin-2 Receptor alpha SubunitHumansLymphocyte ActivationCells, CulturedCoculture TechniquesCell Proliferation

Stichwörter der Autor:innen

CD25CD3+ T-lymphocytesinterferon-γinterleukin-6transforming growth factor-β1umbilical cord mesenchymal stem cells

Substanzen

Interleukin-6Transforming Growth Factor beta1Interferon-gammaInterleukin-2 Receptor alpha SubunitIL2RA protein, humanIL6 protein, human

Autor:innen und Institutionen

  • Department of Pathology, College of Medicine, Jouf University, Sakaka, Saudi Arabia.
  • Department of Anatomy, College of Medicine, Jouf University, Sakaka, Saudi Arabia.
  • Department of Hematology, Faculty of Medicine, Cairo University, Cairo, Egypt.

ORCID-Profile: Abdulrahman H Almaeen, Heba M Saad-Eldien

Förderung

  • the Deanship of Scientific Research at Jouf University for funding this work through the research grant #CV-44-41.

Zitieren

APA

Almaeen, A. H., Saad-Eldien, H. M., & Gabr, H. (2025). INF-γ/TGF-β1-primed umbilical cord mesenchymal stem cells boost the T-lymphocytes activity: Modulation of CD25 expression and IL-6 secretion. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177/03946320251315007

Vancouver

Almaeen AH, Saad-Eldien HM, Gabr H. INF-γ/TGF-β1-primed umbilical cord mesenchymal stem cells boost the T-lymphocytes activity: Modulation of CD25 expression and IL-6 secretion. International Journal of Immunopathology and Pharmacology. 2025. doi:10.1177/03946320251315007

BibTeX
@article{Almaeen2025,
  author = {Almaeen, Abdulrahman H and Saad-Eldien, Heba M and Gabr, Hala},
  title = {INF-γ/TGF-β1-primed umbilical cord mesenchymal stem cells boost the T-lymphocytes activity: Modulation of CD25 expression and IL-6 secretion},
  journal = {International Journal of Immunopathology and Pharmacology},
  year = {2025},
  doi = {10.1177/03946320251315007}
}
Kostenlos starten →